T0	Outcomes 91 138	motor response to acute treatment with levodopa
T1	Outcomes 296 311	bioavailability
T2	Outcomes 791 833	duration of the motor response to levodopa
T3	Outcomes 901 931	Plasma levodopa concentrations
T4	Outcomes 990 1024	latency to onset of motor response
T5	Outcomes 1118 1156	prolonging the duration of the benefit